Overview Dividends

(CX) Cemex SAB de CV - Ratings and Ratios

Exchange: NYSE • Country: Mexico • Currency: USD • Type: Common Stock • ISIN: US1512908898

Cement, Concrete, Aggregates, Prefabricated, Urbanization

CX EPS (Earnings per Share)

EPS Growth (3Y CAGR): 40.16%
EPS Trend (3Y Correlation): 46.6%

CX Revenue

Revenue Growth (3Y CAGR): 3.49%
Revenue Trend (3Y Correlation): -22.2%

Description: CX Cemex SAB de CV October 30, 2025

CEMEX, S.A.B. de C.V. (NYSE: CX) is a Mexico-based, globally diversified construction materials producer that manufactures and sells cement, ready-mix concrete, aggregates, and a range of urbanization and waste-management services through an integrated network of subsidiaries.

The firm’s product slate includes gray and white Portland cement, oil-well and blended cements, as well as specialty concrete mixes such as rapid-setting, fiber-reinforced, self-consolidating, pervious, and antibacterial varieties. It also markets aggregates (crushed stone, manufactured sand, gravel, recycled concrete) and “vertua” solutions, complemented by logistics, pavement, design-engineering, and industrial construction services.

In 2023 CEMEX reported revenue of roughly $15.5 billion, an adjusted EBITDA margin of 13 %, and a net-debt-to-EBITDA ratio of 2.5×, reflecting a modest improvement in profitability and leverage after a year of price-adjustments and cost-control initiatives.

Key drivers of the business include global cement demand growth of about 5 % YoY, accelerated by infrastructure spending in the United States and emerging-market urbanization; rising input costs for energy and clinker-substitutes, which pressure margins; and a sector-wide shift toward low-carbon “green” cement, where CEMEX’s alternative raw-material solutions could provide a competitive edge.

For a deeper, data-rich analysis of CEMEX’s valuation dynamics, you may find the tools on ValueRay useful for building a more quantitative view.

CX Stock Overview

Market Cap in USD	14,731m
Sub-Industry	Construction Materials
IPO / Inception	1999-09-15

CX Stock Ratings

Growth Rating	79.0%
Fundamental	60.3%
Dividend Rating	30.6%
Return 12m vs S&P 500	56.3%
Analyst Rating	3.79 of 5

CX Dividends

Dividend Yield 12m	0.85%
Yield on Cost 5y	2.05%
Annual Growth 5y	%
Payout Consistency	38.3%
Payout Ratio	9.3%

CX Growth Ratios

Growth Correlation 3m	74.9%
Growth Correlation 12m	90.5%
Growth Correlation 5y	23.9%
CAGR 5y	33.72%
CAGR/Max DD 3y (Calmar Ratio)	0.76
CAGR/Mean DD 3y (Pain Ratio)	2.02
Sharpe Ratio 12m	1.98
Alpha	79.76
Beta	1.052
Volatility	32.69%
Current Volume	12582.1k
Average Volume 20d	9667.6k
Stop Loss	9.8 (-3.8%)
Signal	-0.28

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.36b TTM) > 0 and > 6% of Revenue (6% = 950.3m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 1.67pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -3.60% (prev -0.64%; Δ -2.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 2.09b > Net Income 1.36b (YES >=105%, WARN >=100%)

Net Debt (776.3m) to EBITDA (2.28b) ratio: 0.34 <= 3.0 (WARN <= 3.5)

Current Ratio 0.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (147.1m) change vs 12m ago -90.31% (target <= -2.0% for YES)

Gross Margin 31.66% (prev 34.04%; Δ -2.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 55.57% (prev 60.50%; Δ -4.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.11 (EBITDA TTM 2.28b / Interest Expense TTM 517.0m) >= 6 (WARN >= 3)

Altman Z'' 1.81

(A) -0.02 = (Total Current Assets 5.96b - Total Current Liabilities 6.53b) / Total Assets 29.01b

(B) 0.22 = Retained Earnings (Balance) 6.43b / Total Assets 29.01b

(D) 0.80 = Book Value of Equity 13.60b / Total Liabilities 17.06b

Total Rating: 1.81 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.29

1. Piotroski 6.50pt = 1.50

2. FCF Yield 6.46% = 3.23

3. FCF Margin 6.33% = 1.58

4. Debt/Equity 0.17 = 2.49

5. Debt/Ebitda 0.34 = 2.41

6. ROIC - WACC (= -1.99)% = -2.49

7. RoE 10.87% = 0.91

8. Rev. Trend -22.20% = -1.66

9. EPS Trend 46.63% = 2.33

What is the price of CX shares?

As of November 07, 2025, the stock is trading at USD 10.19 with a total of 12,582,075 shares traded.
Over the past week, the price has changed by +0.59%, over one month by +13.35%, over three months by +21.74% and over the past year by +79.47%.

Is Cemex SAB de CV a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Cemex SAB de CV is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 60.29 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CX is around 10.98 USD . This means that CX is currently overvalued and has a potential downside of 7.75%.

Is CX a buy, sell or hold?

Cemex SAB de CV has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold CX.

Strong Buy: 3
Buy: 6
Hold: 4
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	10.5	3%
Analysts Target Price	10.5	3%
ValueRay Target Price	12.3	20.8%

CX Fundamental Data Overview November 02, 2025

Market Cap USD = 14.73b (14.73b USD * 1.0 USD.USD)
P/E Trailing = 11.1538
P/E Forward = 11.1607
P/S = 0.9283
P/B = 0.9838
P/EG = 0.1074
Beta = 1.052
Revenue TTM = 15.84b USD
EBIT TTM = 1.61b USD
EBITDA TTM = 2.28b USD
Long Term Debt = 5.34b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.12b USD (from shortTermDebt, last fiscal year)
Debt = 1.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 776.3m USD (from netDebt column, last quarter)
Enterprise Value = 15.51b USD (14.73b + Debt 1.97b - CCE 1.20b)
Interest Coverage Ratio = 3.11 (Ebit TTM 1.61b / Interest Expense TTM 517.0m)
FCF Yield = 6.46% (FCF TTM 1.00b / Enterprise Value 15.51b)
FCF Margin = 6.33% (FCF TTM 1.00b / Revenue TTM 15.84b)
Net Margin = 8.62% (Net Income TTM 1.36b / Revenue TTM 15.84b)
Gross Margin = 31.66% ((Revenue TTM 15.84b - Cost of Revenue TTM 10.82b) / Revenue TTM)
Gross Margin QoQ = 32.12% (prev 33.96%)
Tobins Q-Ratio = 0.53 (Enterprise Value 15.51b / Total Assets 29.01b)
Interest Expense / Debt = 5.59% (Interest Expense 110.3m / Debt 1.97b)
Taxrate = 33.50% (121.0m / 361.3m)
NOPAT = 1.07b (EBIT 1.61b * (1 - 33.50%))
Current Ratio = 0.91 (Total Current Assets 5.96b / Total Current Liabilities 6.53b)
Debt / Equity = 0.17 (Debt 1.97b / totalStockholderEquity, last quarter 11.63b)
Debt / EBITDA = 0.34 (Net Debt 776.3m / EBITDA 2.28b)
Debt / FCF = 0.77 (Net Debt 776.3m / FCF TTM 1.00b)
Total Stockholder Equity = 12.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 1.36b / Total Assets 29.01b)
RoE = 10.87% (Net Income TTM 1.36b / Total Stockholder Equity 12.56b)
RoCE = 8.99% (EBIT 1.61b / Capital Employed (Equity 12.56b + L.T.Debt 5.34b))
RoIC = 7.17% (NOPAT 1.07b / Invested Capital 14.93b)
WACC = 9.16% (E(14.73b)/V(16.71b) * Re(9.89%) + D(1.97b)/V(16.71b) * Rd(5.59%) * (1-Tc(0.34)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.30%
[DCF Debug] Terminal Value 68.14% ; FCFE base≈801.3m ; Y1≈664.1m ; Y5≈484.0m
Fair Price DCF = 4.57 (DCF Value 6.63b / Shares Outstanding 1.45b; 5y FCF grow -20.64% → 3.0% )
EPS Correlation: 46.63 | EPS CAGR: 40.16% | SUE: -0.27 | # QB: 0
Revenue Correlation: -22.20 | Revenue CAGR: 3.49% | SUE: 0.07 | # QB: 0

Additional Sources for CX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle